文献速递乳房整形与再造显微修复重建

跨学科综合康复路径可改善显微外科乳房再造的实施

An Interdisciplinary, Comprehensive Recovery Pathway Improves Microsurgical Breast Reconstruction Delivery.
PubMed 文献 · Ann Plast Surg · 2024-03-26

本研究回顾性纳入单术者全部自体乳房再造综合康复路径(CRP)病例,并与等量随机选取的、按加速康复外科(ERAS)指南管理的假体组织扩张器患者比较。结果显示自体组术中及门诊阿片类用量更少,住院时间相当,主要并发症无显著差异,但皮瓣失败显著少于假体组(1例 vs 11例失败)。

要点

  • 自体CRP组与假体ERAS组各71例(99侧乳房),均接受术前椎旁区域阻滞。
  • 自体组术中吗啡当量更少(P=0.02),住院期间吗啡当量两组相似,均中位第2天出院。
  • 自体组门诊吗啡当量显著更少,相当于羟考酮30–150 mg差异(P<0.01)。

核心结论

  • 该跨学科综合康复路径使自体乳房再造从手术至随访的阿片类用量少于假体组,住院时间相当,再造失败显著少于假体组。
  • 作者认为该路径可较快纳入学术实践模式并减少传统障碍,从而扩大自体再造的提供。

研究设计与样本

  • 回顾性纳入单术者全部接受自体综合康复路径(CRP)的病例。
  • 从本机构胸下肌与双平面组织扩张器患者中随机选取等量、按加速康复外科(ERAS)指南管理者作为对照。
  • 两组均接受术前椎旁区域阻滞,比较手术细节、住院康复、纵向吗啡当量需求及并发症。

主要发现

  • 每组各71例(99侧乳房),尽管自体组手术时间更长,术中吗啡当量仍更少(P=0.02)。
  • 住院期间吗啡当量两组相似,均中位第2天出院。
  • 多变量回归显示自体组住院时间增加0.8天,双侧病例、体重指数和年龄有额外贡献(P<0.05)。
  • 自体组常规术后第1天出院占17%、第2天占39%,出院趋势提前(P<0.01)。
  • 门诊吗啡当量自体组显著更少,相当于羟考酮30–150 mg差异(P<0.01)。

关键数值与推荐

  • 术中吗啡当量自体组少于假体组(P=0.02)。
  • 住院吗啡当量两组相似,均中位第2天出院。
  • 自体组术后第1天出院17%、第2天39%,出院趋势提前(P<0.01)。
  • 门诊吗啡当量自体组显著更少,相当于羟考酮30–150 mg差异(P<0.01)。
  • 主要并发症自体组12.7% vs 假体组22.5%(P=0.11);皮瓣失败自体组1例 vs 假体组11例失败(P<0.01)。

临床怎么用

  • 作者认为该路径可较快纳入学术实践模式并减少传统障碍,从而扩大自体再造的提供。
  • 原文未据此给出其他推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Free-flap (autologous) breast reconstruction demonstrates superiority over alloplastic approaches but is offered infrequently. Enhanced recovery protocols can address postoperative challenges, but most literature is limited to inpatient interventions and outcomes. This study describes an adoptable, longitudinally comprehensive and multidisciplinary recovery pathway for autologous reconstruction which adds to the current guidelines. The authors aimed to allow perioperative outcomes comparable to alloplastic reconstructions. METHODS: All autologous Comprehensive Recovery Pathway (CRP) subjects from a single surgeon were retrospectively included. A comparator group of equal size was randomly selected from institutional subpectoral and dual-plane tissue expander patients having Enhanced Recovery After Surgery guideline-directed care. All subjects in both cohorts received preoperative paravertebral regional blocks. Operative detail, inpatient recovery, longitudinal morphine equivalents (MEs) required, and complications were compared. RESULTS: Each cohort included 71 cases (99 breasts). Despite longer operations, intraoperative MEs were fewer in autologous cases ( P = 0.02). Morphine equivalents during inpatient stay were similar between cohorts, with both being discharged on median day 2. Multivariate regression demonstrated a 0.8-day increased stay for autologous subjects with additional contribution from bilateral cases, body mass index, and age ( P < 0.05). Autologous subjects were regularly discharged postoperative day 1 (17%) and postoperative day 2 (39%), with trend toward earlier discharge ( P < 0.01). Outpatient MEs were significantly fewer in autologous subjects, corresponding to a 30- to 150-mg oxycodone difference ( P < 0.01). Major complication occurred in 12.7% of autologous and 22.5% of alloplastic subjects ( P = 0.11). Flap loss occurred in 1 autologous subject versus 11 alloplastic failures ( P < 0.01). CONCLUSIONS: This study details partnership between the plastic surgery service, regional and acute pain anesthesia services, and dedicated nursing with longitudinal optimizations allowing perioperative outcomes improved over current literature. Patients in the CRP used fewer opioids from operation through follow-up with comparable length of stay and significantly fewer reconstructive failures than alloplastic subjects. The pathway may be quickly adopted into academic practice patterns and mitigates traditional barriers, allowing extension of autologous reconstruction offerings.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Clark RC, Segal R, Kordahi A, et al. An Interdisciplinary, Comprehensive Recovery Pathway Improves Microsurgical Breast Reconstruction Delivery. Ann Plast Surg. 2024. PMID: 38563567. doi:10.1097/SAP.0000000000003833

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。